We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MEDICA 2024 to Highlight Hot Topics of MedTech Industry

By LabMedica International staff writers
Posted on 08 Nov 2024

Once again this year, everything at MEDICA (Düsseldorf, Germany) will revolve around the major trends and challenges in medical technology. More...

The focus will be on four key topics that will have a lasting impact on the industry: Artificial Intelligence & Big Data, Robotics & Assistive Systems, Connected Care, and Skills Shortage & Staff Development.

The integration of artificial intelligence (AI) and big data into medical technology is revolutionizing healthcare. From precise diagnostics and personalized treatment plans to accelerated drug research – AI and big data are opening doors to new possibilities. At MEDICA 2024, visitors will have the chance to experience exciting solutions and research approaches that raise the efficiency and accuracy of medical procedures to a new level. Experts will present how these technologies support precise navigation during surgical procedures or optimize diagnoses by analyzing large amounts of data. Robotics and assistive systems are changing the way medical treatments are performed. At MEDICA 2024, attendees will experience how surgical robots make minimally invasive procedures more precise and rehabilitation robots speed up the recovery process. These technologies not only offer enormous added value for patients but also relieve the burden on medical staff. Visitors will be inspired by the latest developments that take efficiency and patient safety in the healthcare industry to a new level.

In an increasingly digitalized world, connected care plays a key role in medical technology. The combination of medical devices, digital platforms, and real-time data enables optimized patient care. At MEDICA 2024, everything revolves around connected solutions that enable precise diagnoses and treatments through wearables and implants. Connected care not only offers new possibilities for the treatment of patients but also supports medical professionals in making decisions more efficiently. The shortage of skilled workers poses considerable challenges for the medical technology industry. At MEDICA 2024, visitors will find out how companies are tackling this problem with innovative approaches to personnel development. Training programs, further education offers, and strategic personnel planning are crucial for attracting qualified specialists and retaining them in the long term. Attendees can learn from leading experts how targeted measures can secure the future of medical technology and what the current trends are in the field of personnel development.

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
HPV Test
Allplex HPV28 Detection
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.